Christiane Lynn Haeffele, MD
Cardiovascular Disease (Cardiology) · Stanford
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 18
- 4 carriers
- Offices
- 5
Offices
5 locations · Stanford Health Care · 3,152 clinicians in this group
Hospitals listed: Stanford Health Care. That is not proof they admit you there this week.
Plans that list them
18 plans · 4 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Haeffele’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
18 of 18 plans
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Anthem Full Dual Advantage Aligned (HMO D-SNP) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| SCAN Balance (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Classic (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN MyChoice (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
California Medical Board record
Licence A120280 · Current
Licensed to practise in California · since 2012 · expires 2027-06-30 · Duke University School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend itOverall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for Stanford Health Care
Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.31 (4.24 to 6.37) · 8,661 cases | Worse | Jul 2022 – Jun 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 14.1 (12.7 to 15.7) · 2,191 cases | Worse | Jan 2024 – Dec 2024 |
| Postoperative respiratory failure rateComplications and deaths | 4.08 (1.95 to 6.21) · 5,296 cases | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.317 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.446 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.241 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.7 (0.6 to 0.9) · 3,348 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.06 (0.45 to 1.67) · 5,374 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.86 (0.72 to 1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 166.09 (137.88 to 194.3) · 470 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.1 · 192 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.4 · 146 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.7 · 253 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 6.3 · 880 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 935 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.7 · 501 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.1 · 7,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.13 (0 to 0.27) · 20,799 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.14 to 0.43) · 23,182 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 0.94 (0.2 to 1.68) · 5,694 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.36 (1.54 to 3.19) · 7,846 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.2 (3.76 to 6.64) · 5,603 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.38 (0.23 to 2.53) · 2,211 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.52 (0.21 to 0.83) · 19,915 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.6 · 416 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.869 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.857 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.368 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16.2 · 247 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.5 · 1,021 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 47.8 · 258 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -1.6 · 990 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 20.8 · 976 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.5 · 959 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (4.4 to 6.2) · 2,191 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 425 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.6 · 158 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 183 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.7 (10.4 to 15.4) · 4,578 cases | No different | Jan 2022 – Dec 2024 |
What patients said (6,810 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 82% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 79% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 83% |
| Staff "always" explained possible side effects | 50% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$103,616
Medicare paid this office $103,616 for 1,167 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 569 | $36,285 | $60 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 162 | $22,790 | $139 |
| Ultrasound of heart with probe in esophagus during surgery on heart or great blood vessels with report | 32 | $6,324 | $198 |
| Long return visit (40+ min) | 47 | $6,279 | $131 |
| Ultrasound of heart with probe in esophagus, with report | 63 | $6,053 | $95 |
See all 19 services
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 569 | $36,285 | $60 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 162 | $22,790 | $139 |
| Ultrasound of heart with probe in esophagus during surgery on heart or great blood vessels with report | 32 | $6,324 | $198 |
| Long return visit (40+ min) | 47 | $6,279 | $131 |
| Ultrasound of heart with probe in esophagus, with report | 63 | $6,053 | $95 |
| Ultrasound of heart during rest, exercise and/or drug-induced stress with report | 55 | $3,274 | $60 |
| Ultrasound of heart, follow-up | 42 | $2,623 | $61 |
| Ultrasound of heart, follow-up | 113 | $2,478 | $22 |
| Ultrasound of heart blood flow, valves and chambers | 115 | $1,865 | $16 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 22 | $1,577 | $72 |
| Ultrasound of heart for congenital defect | 23 | $1,226 | $53 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 54 | $1,020 | $19 |
| 3d ultrasound imaging of heart for evaluation of heart structure performed during ultrasound imaging of congenital heart defects | 41 | $860 | $20 |
| Ultrasound of heart blood flow, valves and chambers, follow-up | 48 | $826 | $17 |
| Ultrasound of heart blood flow, valves and chambers, follow-up | 120 | $751 | $6 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 69 | $530 | $7 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 31 | $388 | $13 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 17 | $344 | $20 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 106 | $291 | $3 |
Who their Medicare patients are
1,167 Original Medicare patients in 2024. Average age 74 · Under 65 11% · 85 and older 18% · Women 51% · Also on Medicaid 28% · Health risk score 2.08. Above the middle of the specialty; the typical cardiology clinician is at 1.71.
Conditions among them: High blood pressure 75% · Coronary heart disease 48% · Heart failure 47% · Atrial fibrillation 44% · Chronic kidney disease 42% · Diabetes 35% · Cancer 22% · Depression 21% · COPD 20% · Stroke 18% · Dementia 12%.
The office billed $971,576, Medicare allowed $132,538 and paid $103,616; for 1,868 services of 25 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 1,167 | 1,868 | 74 | 2.08 | $971,576 | $103,616 |
| 2023 | 1,572 | 2,611 | 74 | 2.28 | $1,098,893 | $126,839 |
| 2022 | 1,058 | 1,952 | 74 | 2.14 | $764,022 | $100,793 |
| 2021 | 1,176 | 2,178 | 74 | 2.03 | $802,051 | $110,905 |
| 2020 | 951 | 1,621 | 73 | 2.15 | $656,216 | $96,246 |
| 2019 | 990 | 1,605 | 74 | 2.26 | $438,285 | $84,563 |
| 2018 | 794 | 1,366 | 73 | 2.22 | $338,641 | $81,743 |
| 2017 | 810 | 1,253 | 74 | 2.09 | $283,277 | $62,131 |
| 2016 | 24 | 53 | 78 | 1.75 | $25,724 | $4,929 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 22 services
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 811 | $50,087 | $58 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 110 | $16,018 | $142 |
| Long return visit (40+ min) | 60 | $11,386 | $131 |
| Ultrasound of heart with probe in esophagus, with report | 80 | $7,931 | $98 |
| Ultrasound of heart with probe in esophagus during surgery on heart or great blood vessels with report | 36 | $7,546 | $204 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 18 | $4,244 | $109 |
| Ultrasound of heart, follow-up | 171 | $3,741 | $21 |
| Ultrasound of heart during rest, exercise and/or drug-induced stress with report | 61 | $3,438 | $56 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 261 | $2,207 | $7 |
| Ultrasound of heart for congenital defect | 39 | $2,198 | $49 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 18 | $2,006 | $111 |
| Ultrasound of heart blood flow, valves and chambers | 119 | $1,955 | $16 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 15 | $1,678 | $73 |
| Ultrasound of heart, follow-up | 33 | $1,658 | $50 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 61 | $1,082 | $18 |
| Ultrasound of heart blood flow, valves and chambers, follow-up | 167 | $1,072 | $6 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 52 | $593 | $11 |
| Heart rhythm review and interpretation of continous external ekg over 8-15 days | 25 | $574 | $23 |
| 3d ultrasound imaging of heart for evaluation of heart structure performed during ultrasound imaging of congenital heart defects | 23 | $503 | $22 |
| 3d radiographic procedure with computerized image postprocessing | 14 | $492 | $35 |
| Ultrasound of heart blood flow, valves and chambers, follow-up | 34 | $443 | $13 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 124 | $355 | $3 |
2022: 22 services
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 547 | $34,786 | $61 |
| Ultrasound of heart with probe in esophagus during surgery on heart or great blood vessels with report | 56 | $11,577 | $203 |
| Long return visit (40+ min) | 52 | $9,499 | $125 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 32 | $8,140 | $94 |
| Ultrasound of heart with probe in esophagus, with report | 48 | $4,698 | $96 |
| Ultrasound of heart during rest, exercise and/or drug-induced stress with report | 66 | $3,881 | $58 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 52 | $3,510 | $68 |
| Ultrasound of heart for congenital defect | 48 | $2,651 | $50 |
| Ultrasound of heart, follow-up | 110 | $2,497 | $22 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 19 | $2,336 | $123 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 22 | $2,092 | $91 |
| Ultrasound of heart blood flow, valves and chambers | 113 | $1,763 | $15 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 58 | $1,078 | $18 |
| 3d radiographic procedure with computerized image postprocessing | 28 | $992 | $34 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 111 | $946 | $8 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 58 | $724 | $12 |
| Ultrasound of heart blood flow, valves and chambers, follow-up | 110 | $703 | $6 |
| Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | 11 | $497 | $28 |
| Ultrasound of heart, follow-up | 12 | $495 | $41 |
| Heart rhythm review and interpretation of continous external ekg over 8-15 days | 16 | $400 | $25 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 135 | $375 | $3 |
| Ultrasound of heart blood flow, valves and chambers, follow-up | 12 | $132 | $11 |
2021: 20 services
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 628 | $40,656 | $61 |
| Ultrasound of heart with probe in esophagus during surgery on heart or great blood vessels with report | 61 | $12,849 | $211 |
| Long return visit (40+ min) | 51 | $8,896 | $124 |
| Ultrasound of heart with probe in esophagus, with report | 67 | $6,869 | $100 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 65 | $5,370 | $83 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 23 | $5,346 | $95 |
| Ultrasound of heart during rest, exercise and/or drug-induced stress with report | 78 | $4,881 | $63 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 22 | $4,071 | $185 |
| Ultrasound of heart, follow-up | 116 | $2,648 | $22 |
| Ultrasound of heart for congenital defect | 42 | $2,448 | $52 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 162 | $1,918 | $8 |
| Ultrasound of heart blood flow, valves and chambers | 104 | $1,760 | $16 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 13 | $1,394 | $66 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 75 | $1,387 | $18 |
| 3d radiographic procedure with computerized image postprocessing | 36 | $1,339 | $36 |
| Hospital discharge day management, more than 30 minutes | 13 | $1,301 | $100 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 75 | $933 | $12 |
| Ultrasound of heart blood flow, valves and chambers, follow-up | 103 | $663 | $6 |
| Heart rhythm review and interpretation of continous external ekg over 8-15 days | 25 | $636 | $25 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 140 | $417 | $3 |
2020: 19 services
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 566 | $37,729 | $64 |
| Ultrasound of heart with probe in esophagus during surgery on heart or great blood vessels with report | 45 | $9,681 | $215 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 30 | $8,052 | $97 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 25 | $4,710 | $181 |
| Ultrasound of heart with probe in esophagus, with report | 46 | $4,613 | $100 |
| Long return visit (40+ min) | 30 | $4,294 | $100 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 45 | $3,991 | $89 |
| Ultrasound of heart during rest, exercise and/or drug-induced stress with report | 59 | $3,724 | $63 |
| Ultrasound of heart, follow-up | 113 | $2,772 | $23 |
| Ultrasound of heart for congenital defect | 32 | $1,750 | $55 |
| Return visit (30+ min) | 18 | $1,327 | $70 |
| Hospital discharge day management, more than 30 minutes | 11 | $1,199 | $92 |
| Ultrasound of heart blood flow, valves and chambers | 67 | $1,112 | $16 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 52 | $949 | $18 |
| Ultrasound of heart blood flow, valves and chambers, follow-up | 93 | $662 | $7 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 52 | $637 | $12 |
| 3d radiographic procedure with computerized image postprocessing | 17 | $633 | $37 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 89 | $260 | $3 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 13 | $147 | $11 |
2019: 18 services
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 574 | $37,998 | $64 |
| Ultrasound of heart with probe in esophagus during surgery on heart or great blood vessels with report | 43 | $9,462 | $210 |
| Long return visit (40+ min) | 49 | $7,183 | $97 |
| Ultrasound of heart during rest, exercise and/or drug-induced stress with report | 72 | $4,301 | $60 |
| Return visit (30+ min) | 34 | $2,799 | $65 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 12 | $2,785 | $87 |
| Ultrasound of heart with probe in esophagus, with report | 19 | $1,907 | $100 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 22 | $1,769 | $80 |
| Ultrasound of heart, follow-up | 67 | $1,596 | $23 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 141 | $1,238 | $8 |
| Ultrasound of heart for congenital defect | 20 | $1,227 | $53 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 65 | $1,142 | $18 |
| Hospital discharge day management, more than 30 minutes | 12 | $1,130 | $94 |
| Ultrasound of heart blood flow, valves and chambers | 64 | $1,060 | $16 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 65 | $774 | $12 |
| Review and interpretation of external ekg recording for more than 48 hours up to 21 days | 18 | $466 | $25 |
| Ultrasound of heart blood flow, valves and chambers, follow-up | 47 | $318 | $7 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 74 | $217 | $3 |
2018: 21 services
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 432 | $27,608 | $63 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 36 | $8,988 | $94 |
| Long return visit (40+ min) | 54 | $8,617 | $93 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 32 | $5,759 | $180 |
| Ultrasound of heart during rest, exercise and/or drug-induced stress with report | 54 | $3,427 | $63 |
| Hospital discharge day management, more than 30 minutes | 28 | $2,666 | $95 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 20 | $2,625 | $119 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 16 | $2,622 | $64 |
| Ultrasound of heart with probe in esophagus during surgery on heart or great blood vessels with report | 12 | $2,380 | $198 |
| Initial hospital observation care per day, typically 70 minutes | 15 | $2,341 | $156 |
| Return visit (30+ min) | 25 | $2,146 | $67 |
| Ultrasound of heart with probe in esophagus, with report | 19 | $1,780 | $94 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 130 | $1,055 | $8 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 15 | $991 | $66 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 51 | $973 | $19 |
| Ultrasound of heart for congenital defect | 14 | $752 | $50 |
| Ultrasound of heart, follow-up | 30 | $722 | $23 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 51 | $666 | $13 |
| Ultrasound of heart blood flow, valves and chambers | 40 | $634 | $15 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 55 | $154 | $3 |
| Ultrasound of heart blood flow, valves and chambers, follow-up | 21 | $145 | $7 |
2017: 19 services
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 370 | $21,295 | $57 |
| Ultrasound of heart with probe in esophagus during surgery on heart or great blood vessels with report | 37 | $7,498 | $203 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 29 | $4,851 | $65 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 21 | $2,558 | $122 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 13 | $2,520 | $93 |
| Long return visit (40+ min) | 22 | $2,491 | $100 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 264 | $2,376 | $8 |
| Ultrasound of heart during rest, exercise and/or drug-induced stress with report | 38 | $2,324 | $61 |
| New patient visit (45+ min) | 20 | $2,144 | $107 |
| Return visit (30+ min) | 22 | $1,989 | $66 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 17 | $1,615 | $90 |
| Ultrasound of heart for congenital defect | 18 | $1,228 | $56 |
| Hospital discharge day management, 30 minutes or less | 13 | $861 | $66 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 34 | $642 | $19 |
| Ultrasound of heart blood flow, valves and chambers | 33 | $609 | $16 |
| Review and interpretation of external ekg recording for more than 48 hours up to 21 days | 17 | $441 | $24 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 34 | $431 | $13 |
| Ultrasound of heart, follow-up | 13 | $303 | $23 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 38 | $121 | $3 |
Medicaid work
$26,489 in 2024
Medicaid paid $26,489 for 583 billed services this clinician did in 2024, up to 90 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 441 | $24,119 |
| ECHO TRANSTHORC R-T 2D W/WO M-MODE REC F-UP/LMTD | 39 | $1,014 |
| DOPPLER ECHO PULSE WAVE W/SPECTRAL F-UP/LMTD STD | 39 | $486 |
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 30 | $360 |
| DOPPLER ECHO COMPLETE | 18 | $312 |
| Doppler echocardiography color flow velocity mapping (List separately in addition to codes for echocardiography) | 16 | $198 |
| 2024 | 583 | 6 | 90 | $26,489 |
| 2023 | 1,205 | 9 | 118 | $47,596 |
| 2022 | 623 | 7 | 88 | $25,395 |
| 2021 | 737 | 7 | 140 | $26,302 |
| 2020 | 320 | 1 | 42 | $16,819 |
| 2019 | 317 | 2 | 39 | $13,021 |
| 2018 | 246 | 2 | 47 | $9,009 |
See the largest Medicaid services in earlier years
2023
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 598 | $37,690 |
| ECHO TRANSTHORC R-T 2D W/WO M-MODE REC F-UP/LMTD | 111 | $3,403 |
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 247 | $2,620 |
| DOPPLER ECHO PULSE WAVE W/SPECTRAL F-UP/LMTD STD | 92 | $1,139 |
| Complete transthoracic echocardiography for congenital cardiac anomalies | 25 | $955 |
| DOPPLER ECHO COMPLETE | 46 | $771 |
| Long return visit (40+ min) | 14 | $537 |
| 1ST HOSPITAL IP/OBS CARE MODERATE MDM 55 MINUTES | 12 | $400 |
| Doppler echocardiography color flow velocity mapping (List separately in addition to codes for echocardiography) | 60 | $82 |
2022
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 358 | $20,704 |
| DOPPLER ECHO COMPLETE | 49 | $1,269 |
| Complete transthoracic echocardiography for congenital cardiac anomalies | 15 | $1,173 |
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 97 | $1,015 |
| ECHO TRANSTHORC R-T 2D W/WO M-MODE REC F-UP/LMTD | 29 | $873 |
| DOPPLER ECHO PULSE WAVE W/SPECTRAL F-UP/LMTD STD | 13 | $207 |
| Doppler echocardiography color flow velocity mapping (List separately in addition to codes for echocardiography) | 62 | $154 |
2021
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 401 | $20,530 |
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 188 | $2,577 |
| DOPPLER ECHO COMPLETE | 45 | $1,201 |
| Complete transthoracic echocardiography for congenital cardiac anomalies | 13 | $1,060 |
| ECHO TRANSTHORC R-T 2D W/WO M-MODE REC F-UP/LMTD | 30 | $581 |
| Doppler echocardiography color flow velocity mapping (List separately in addition to codes for echocardiography) | 45 | $212 |
| DOPPLER ECHO PULSE WAVE W/SPECTRAL F-UP/LMTD STD | 15 | $142 |
2020
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 320 | $16,819 |
2019
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 247 | $12,178 |
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 70 | $843 |
2018
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 144 | $7,832 |
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 102 | $1,176 |
Drugs they prescribed that Part D paid
$51,192
Pharmacies billed $51,192 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 192) in 2024. At or below the middle of the specialty; the typical cardiology clinician is at 0%.
145 generic and 47 brand-name prescriptions · $51,192 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Eliquis | 31 | $27,850 | $898 |
| Atorvastatin | 29 | $412 | $14 |
| Metoprolol | 26 | $386 | $15 |
| Rosuvastatin | 11 | $184 | $17 |
| Losartan | 14 | $172 | $12 |
Year by year
| 2024 | 192 | 32 | 0% (0) | 24% | $51,192 |
| 2023 | 262 | 48 | 0% (0) | 22% | $70,446 |
| 2022 | 348 | 54 | 0% (0) | None | $84,941 |
| 2021 | 395 | 54 | None | 24% | $78,634 |
| 2020 | 404 | 56 | 0% (0) | 22% | $67,447 |
| 2019 | 590 | 84 | 0% (0) | 19% | $75,492 |
| 2018 | 603 | 83 | 0% (0) | 21% | $67,852 |
| 2017 | 200 | 45 | 0% (0) | 19% | $15,905 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 8 drugs
| Eliquis | 24 | $21,569 | $899 |
| Entresto | 15 | $18,798 | $1,253 |
| Metoprolol | 39 | $665 | $17 |
| Atorvastatin | 28 | $500 | $18 |
| Clopidogrel | 13 | $355 | $27 |
| Spironolactone | 14 | $300 | $21 |
| Rosuvastatin | 15 | $260 | $17 |
| Furosemide | 20 | $232 | $12 |
2022: 8 drugs
| Eliquis | 50 | $43,759 | $875 |
| Metoprolol | 53 | $1,142 | $22 |
| Rosuvastatin | 18 | $941 | $52 |
| Atorvastatin | 47 | $782 | $17 |
| Losartan | 28 | $398 | $14 |
| Furosemide | 18 | $209 | $12 |
| Clopidogrel | 20 | $179 | $9 |
| Lisinopril | 11 | $33 | $3 |
2021: 9 drugs
| Eliquis | 47 | $43,305 | $921 |
| Vascepa | 11 | $3,991 | $363 |
| Metoprolol | 55 | $1,664 | $30 |
| Atorvastatin | 46 | $1,074 | $23 |
| Potassium Chloride | 11 | $477 | $43 |
| Losartan | 30 | $417 | $14 |
| Furosemide | 23 | $250 | $11 |
| Lisinopril | 14 | $147 | $11 |
| Clopidogrel | 19 | $135 | $7 |
2020: 8 drugs
| Eliquis | 37 | $32,239 | $871 |
| Metoprolol | 56 | $1,729 | $31 |
| Atorvastatin | 59 | $1,103 | $19 |
| Losartan | 38 | $788 | $21 |
| Furosemide | 20 | $326 | $16 |
| Clopidogrel | 15 | $141 | $9 |
| Carvedilol | 21 | $119 | $6 |
| Metoprolol | 11 | $101 | $9 |
2019: 11 drugs
| Eliquis | 57 | $41,702 | $732 |
| Metoprolol | 62 | $1,954 | $32 |
| Rosuvastatin | 22 | $1,319 | $60 |
| Atorvastatin | 63 | $1,200 | $19 |
| Isosorbide Mononitrate Er | 15 | $405 | $27 |
| Losartan | 45 | $375 | $8 |
| Clopidogrel | 34 | $313 | $9 |
| Furosemide | 38 | $311 | $8 |
| Carvedilol | 36 | $273 | $8 |
| Lisinopril | 17 | $218 | $13 |
| Metoprolol | 16 | $96 | $6 |
2018: 18 drugs
| Eliquis | 63 | $33,783 | $536 |
| Xarelto | 20 | $8,838 | $442 |
| Prasugrel | 11 | $1,046 | $95 |
| Metoprolol | 30 | $1,009 | $34 |
| Atorvastatin | 60 | $943 | $16 |
| Rosuvastatin | 12 | $825 | $69 |
| Omega-3 Acid Ethyl Esters | 13 | $474 | $36 |
| Furosemide | 53 | $443 | $8 |
| Midodrine | 11 | $381 | $35 |
| Metoprolol | 19 | $279 | $15 |
| Diltiazem | 17 | $277 | $16 |
| Clopidogrel | 22 | $273 | $12 |
| Carvedilol | 28 | $270 | $10 |
| Losartan | 29 | $268 | $9 |
| Lisinopril | 33 | $198 | $6 |
| Amlodipine Besylate | 22 | $179 | $8 |
| Spironolactone | 14 | $153 | $11 |
| Quinapril | 12 | $104 | $9 |
2017: 8 drugs
| Eliquis | 17 | $8,855 | $521 |
| Amiodarone | 12 | $1,149 | $96 |
| Metoprolol | 12 | $253 | $21 |
| Carvedilol | 11 | $228 | $21 |
| Atorvastatin | 15 | $164 | $11 |
| Diltiazem | 12 | $107 | $9 |
| Metoprolol | 12 | $66 | $6 |
| Amlodipine Besylate | 12 | $60 | $5 |
Money from drug and device companies
$12,170 in 2025
| 2025 | 2 | 32 | $9,188 | $12,170 |
| 2024 | 2 | 33 | $19,225 | $23,878 |
| 2023 | 2 | 49 | $18,031 | $22,929 |
| 2022 | 3 | 33 | None | $2,065 |
| 2021 | 3 | 31 | $3,250 | $5,687 |
| 2020 | 2 | 14 | $2,031 | $3,034 |
| 2019 | 3 | 18 | None | $2,862 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Edwards Lifesciences | Evoque | $12,072 | 31 payments
|
| Philips North America | US Eq Undivided | $98 | 1 payment
|
See all 32 published payments
| Edwards Lifesciences | Meals · 2025-10-29 | Pascal | $34 |
| Edwards Lifesciences | Meals · 2025-10-28 | None | $18 |
| Edwards Lifesciences | Travel · 2025-10-08 | None | $496 |
| Edwards Lifesciences | Travel · 2025-10-06 | None | $20 |
| Edwards Lifesciences | Travel · 2025-10-06 | None | $7 |
| Edwards Lifesciences | Travel · 2025-10-06 | None | $5 |
| Edwards Lifesciences | Travel · 2025-10-06 | None | $20 |
| Edwards Lifesciences | Travel · 2025-10-06 | None | $23 |
| Edwards Lifesciences | Travel · 2025-10-06 | None | $5 |
| Edwards Lifesciences | Travel · 2025-10-06 | None | $20 |
| Edwards Lifesciences | Meals · 2025-10-06 | None | $6 |
| Edwards Lifesciences | Meals · 2025-10-06 | None | $13 |
| Edwards Lifesciences | Meals · 2025-10-06 | None | $15 |
| Edwards Lifesciences | Meals · 2025-10-02 | None | $12 |
| Edwards Lifesciences | Meals · 2025-10-02 | None | $7 |
| Edwards Lifesciences | Meals · 2025-10-02 | None | $25 |
| Edwards Lifesciences | Meals · 2025-10-02 | None | $5 |
| Edwards Lifesciences | Meals · 2025-10-02 | None | $28 |
| Edwards Lifesciences | Meals · 2025-10-02 | None | $13 |
| Edwards Lifesciences | Travel · 2025-09-26 | None | $489 |
| Edwards Lifesciences | Meals · 2025-09-17 | Sapien 3 Ultra Resilia | $223 |
| Philips North America | Meals · 2025-09-05 | US Eq Undivided | $98 |
| Edwards Lifesciences | Meals · 2025-06-26 | None | $222 |
| Edwards Lifesciences | Meals · 2025-06-20 | Evoque | $220 |
| Edwards Lifesciences | Consulting · 2025-04-03 | Evoque | $4,988 |
| Edwards Lifesciences | Meals · 2025-04-03 | Pascal | $32 |
| Edwards Lifesciences | Travel · 2025-03-28 | Evoque | $317 |
| Edwards Lifesciences | Meals · 2025-03-12 | Evoque | $37 |
| Edwards Lifesciences | Travel · 2025-02-24 | None | $387 |
| Edwards Lifesciences | Travel · 2025-02-24 | None | $185 |
| Edwards Lifesciences | Consulting · 2025-01-20 | Evoque | $2,625 |
| Edwards Lifesciences | Consulting · 2025-01-16 | Evoque | $1,575 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $23,878
| Edwards Lifesciences | Evoque | $22,895 | 26 payments
|
| Abbott Laboratories | None | $983 | 7 payments
|
2023: $22,929
| Edwards Lifesciences | Edwards Sapien 3 Ultra Transcatheter Heart Valve | $22,789 | 43 payments
|
| Abbott Laboratories | Mitraclip | $140 | 6 payments
|
2022: $2,065
| Edwards Lifesciences | Edwards Sapien 3 Transcatheter Heart Valve (Thv) | $889 | 9 payments
|
| Abbott Laboratories | Mitraclip | $745 | 20 payments
|
| Medtronic | Harmony | $431 | 4 payments
|
2021: $5,687
| Edwards Lifesciences | Edwards Sapien 3 Ultra Transcatheter Heart Valve | $4,490 | 9 payments
|
| Abbott Laboratories | Mitraclip System | $1,006 | 20 payments
|
| Philips Electronics North America | (1262) Large Scale Upgrades | $191 | 2 payments
|
2020: $3,034
| Edwards Lifesciences | None | $2,706 | 8 payments
|
| Abbott Laboratories | Mitra Clip System | $329 | 6 payments
|
2019: $2,862
| Medtronic Vascular | None | $1,502 | 8 payments
|
| Edwards Lifesciences | None | $1,215 | 9 payments
|
| Abbott Laboratories | Mitra Clip System | $145 | 1 payment
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 76.5 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1477753614
- Licence
- CA A120280, MA 233375California A120280: Current · expires 2027-06-30
- Trained
- Duke University School of Medicine, 2007
- Group
- Stanford Health Care
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Cardiology (207RC0000X); Internal medicine (207R00000X); Federal specialty code 207RA0002X (207RA0002X); Federal specialty code 207RI0011X (207RI0011X)
- Mailing address
- 300 Pasteur Dr, Stanford, CA, 94305
- NPI first listed
- 2007-07-24
- NPI last updated
- 2024-04-20
- NPI record certified
- 2024-04-20
This is when the NPI record was last certified, not a medical board exam.